References
De Leon J (2006) AmpliChip CYP450 Test: personalized medicine has arrived in psychiatry. Exp Rev Mol Diagn 6:277–286
Flint J, Munafo MR (2007) The endophenotype concept in psychiatric genetics. Psychol Med 37:163–180
Kendler KS (2006) Reflections on the relationship between psychiatric genetics and psychiatric nosology. Am J Psychiatry 163:1138–1146
Malhotra AK, Murphy GM, Kennedy JL (2004) Pharmacogenetics of psychotropic drug response. Am J Psychiatry 161:780–796
Murray M (2006) Role of CYP pharmacogenetics and drug–drug interactions in the efficacy and safety of atypical and other antipsychotic agents. JPP 58:871–885
Preskorn SH (2006) Pharmacogenomics, informatics, and individual drug therapy in psychiatry: past, present and future. J Psychopharmacol 20(suppl.):85–94
Robert JS, Plantikow T (2005) Genetics, neuroscience and psychiatric classification. Psychopathology 38:215–218
Vandel P, Talon JM, Haffen E, Sechter D (2007) Pharmacogenetics and drug therapy in psychiatry—the role of the CYP2D6 Polymorphism. Curr Pharmaceut Des 13:241–250
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Broich, K., Möller, H.J. Pharmacogenetics, pharmacogenomics and personalized psychiatry: Are we there yet?. Eur Arch Psychiatry Clin Neurosc 258 (Suppl 1), 1–2 (2008). https://doi.org/10.1007/s00406-008-1001-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00406-008-1001-x